Study Acknowledges COVID-19 Vaccine Risks ‘Outweigh the Rewards’

A study published in the digital journal Cureus acknowledged that the risks presented by the COVID-19 mRNA vaccines “outweigh the rewards.”

It suggested that “for every life saved, there were nearly 14 times more deaths caused by the modified mRNA injections.”

According to the study’s authors, the claim that the mRNA vaccines were “safe and effective” was “dubious at best,” explaining that it took an estimated 52,000 vaccinations to prevent one death.

“Federal agency approval of the COVID-19 mRNA vaccines on a blanket-coverage population-wide basis had no support from an honest assessment of all relevant registrational data and commensurate consideration of risks versus benefits,” the study added. “Given the extensive, well-documented SAEs [serious adverse events] and unacceptably high harm-to-reward ratio, we urge governments to endorse a global moratorium on the modified mRNA products until all relevant questions pertaining to causality, residual DNA, and aberrant protein production are answered.”

The authors noted that due to the risks of mRNA inoculations, it is “unethical and unconscionable to administer an experimental vaccine to a child who has a near-zero risk of dying from COVID-19 but a well-established 2.2% risk of permanent heart damage based on the best prospective data available.”

Similar concerns regarding mRNA vaccines were raised by German chemistry professors.

The professors sent a letter to the Paul Ehrlich Institute (PEI), writing that “the problems with modRNA-based vaccines are becoming increasingly apparent.”

They cited a study from the journal Nature, where unwanted proteins were discovered in patients who received an mRNA inoculation.

The German scientists asked PEI, “When did you become aware of this work and the problem of the ribosomal shift in modRNA-based injections? Why wasn’t this obvious problem recognized earlier? What investigations are planned by the PEI to investigate the toxicity of the unwanted proteins and what steps are planned by the PEI to eliminate or at least reduce such threats to modRNA technology?”

“From the PEI’s perspective, should these new findings have an impact on the approval of these new modRNA-based drugs and if so, which ones and if no, why not? How does PEI plan to inform the public about these new findings about potentially dangerous side effects of modRNA technology,” the letter asked.